Lannett Company logo
Lannett Company LCI

Quartalsbericht 2023-Q3
hinzugefügt 13.06.2026

report update icon

Lannett Company Gesamtverbindlichkeiten 2011-2026 | LCI

Gesamtverbindlichkeiten Jährlich Lannett Company

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
735 M 711 M 834 M 853 M 976 M 1.04 B 1.21 B 45 M 48 M 38.9 M 31.3 M 42.1 M - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.21 B 31.3 M 547 M

Gesamtverbindlichkeiten Vierteljährlich Lannett Company

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
747 M 751 M 745 M 751 M 732 M 721 M 738 M 721 M 738 M 771 M 833 M 771 M 849 M 856 M 854 M 856 M 892 M 993 M 946 M 993 M 991 M 1.07 B 1.04 B 1.07 B 1.07 B 1.22 B 1.21 B 1.22 B 1.2 B 1.2 B 41.1 M 1.2 B 35.8 M 44.1 M 41.4 M 44.1 M 38.3 M 35.6 M 30 M 35.6 M 46.4 M 50.3 M 43.9 M 50.3 M 41.9 M 40.8 M 41.7 M 40.8 M 41.7 M 42.1 M 42.1 M

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
1.22 B 30 M 580 M

Gesamtverbindlichkeiten anderer Aktien in der Arzneimittelhersteller

Name Gesamtverbindlichkeiten Preis % 24h Marktkapitalisierung Land
Endo International plc Endo International plc
ENDP
10.3 B - - $ 28.9 M irlandaIrlanda
Evoke Pharma Evoke Pharma
EVOK
10.5 M - - $ 36.6 M usaUSA
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
52.3 M $ 5.59 -0.27 % $ 83 M usaUSA
HEXO Corp. HEXO Corp.
HEXO
367 M - 2.45 % $ 38.1 M canadaCanada
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
250 M - -0.1 % $ 2.03 B schwedenSchweden
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
12.7 M - 7.5 % $ 6.35 M usaUSA
DURECT Corporation DURECT Corporation
DRRX
63.2 M - - $ 50.1 M usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
11.6 M - 0.86 % $ 117 M usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
449 M - - $ 754 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
26.6 M - 10.11 % $ 58.2 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
107 M - - $ 142 M usaUSA
Cronos Group Cronos Group
CRON
54.2 M $ 2.66 -0.93 % $ 1.02 B canadaCanada
Athenex Athenex
ATNX
228 M - -23.39 % $ 1.76 M usaUSA
Harrow Health Harrow Health
HROW
347 M $ 39.34 4.5 % $ 1.45 B usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
90.4 M - - $ 2.06 B franceFrance
Catalent Catalent
CTLT
6.15 B - - $ 11.5 B usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
165 M $ 2.38 1.71 % $ 302 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
173 M - -39.89 % $ 27.7 M usaUSA
Pacira BioSciences Pacira BioSciences
PCRX
775 M $ 22.84 -0.65 % $ 1.06 B usaUSA
Canopy Growth Corporation Canopy Growth Corporation
CGC
430 M $ 1.02 2.01 % $ 110 M canadaCanada
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
9.28 M $ 1.15 5.4 % $ 1.43 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
244 M $ 3.17 4.11 % $ 174 M canadaCanada
Solid Biosciences Solid Biosciences
SLDB
52.5 M $ 7.39 3.5 % $ 647 M usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
5.98 M - - $ 33.6 M usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
102 M $ 1.06 -0.47 % $ 101 M canadaCanada
Tilray Tilray
TLRY
977 M $ 5.11 2.51 % $ 3.16 B canadaCanada
Evolus Evolus
EOLS
249 M $ 6.66 -1.04 % $ 429 M usaUSA
Sundial Growers Sundial Growers
SNDL
235 M $ 1.44 1.75 % $ 3.37 M canadaCanada
Emergent BioSolutions Emergent BioSolutions
EBS
796 M $ 8.35 0.36 % $ 447 M usaUSA
cbdMD cbdMD
YCBD
3.19 M $ 0.7 2.06 % $ 2.82 M usaUSA
Veru Veru
VERU
11.5 M $ 3.13 4.33 % $ 45.8 M usaUSA
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
23.7 M - - $ 193 M canadaCanada
Assertio Holdings Assertio Holdings
ASRT
173 M $ 23.49 0.04 % $ 150 M usaUSA
ProPhase Labs ProPhase Labs
PRPH
56.4 M - - $ 5.07 M usaUSA
Radius Health Radius Health
RDUS
434 M - - $ 1.42 B usaUSA
Bausch Health Companies Bausch Health Companies
BHC
26 B $ 5.08 0.4 % $ 1.88 B canadaCanada
PetIQ PetIQ
PETQ
478 M - 1.64 % $ 400 M usaUSA
Relmada Therapeutics Relmada Therapeutics
RLMD
7.49 M $ 6.81 2.33 % $ 269 M usaUSA
Recro Pharma Recro Pharma
REPH
94.8 M - -4.76 % $ 65.3 M usaUSA
OptiNose OptiNose
OPTN
169 M - - $ 1.08 B usaUSA
SCYNEXIS SCYNEXIS
SCYX
9.65 M $ 4.31 1.89 % $ 215 M usaUSA
PLx Pharma PLx Pharma
PLXP
25 M - -27.8 % $ 2.56 M usaUSA
Viatris Viatris
VTRS
22.5 B $ 16.42 -0.39 % $ 19.2 B usaUSA
Zomedica Corp. Zomedica Corp.
ZOM
11.6 M - -0.21 % $ 98 M usaUSA
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
9.29 M - - $ 55.5 M usaUSA
Rockwell Medical Rockwell Medical
RMTI
20.2 M $ 0.65 3.92 % $ 23.4 M usaUSA
Tricida Tricida
TCDA
168 M - - $ 3.25 M usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
8.26 M $ 0.74 -0.15 % $ 3.18 M chinaChina
TherapeuticsMD TherapeuticsMD
TXMD
10.8 M $ 2.29 4.09 % $ 26.5 M usaUSA